This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Colorado. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Innovations of James M Kovacs in Complement System Modulation
Introduction: James M Kovacs is an accomplished inventor based in Monument, Colorado. He has made significant contributions to the field of complement system modulation through his innovative research and patent work. His expertise lies in developing targeted delivery systems for complement activity modulators.
Latest Patents: James M Kovacs holds 1 patent related to his work on Complement receptor 2 (CR2) targeting groups. This patent provides compositions and methods directed to soluble proteins that can selectively deliver modulators of complement activity. The targeted delivery is achieved by selectively mutating specific amino acids in a targeting protein portion of the composition, which corresponds to the first two N-terminal SCR domains of CR2. This innovative approach allows for the selective delivery of complement activity modulators to specific ligands of CR2, particularly at sites where activation or suppression of the complement system is desired.
Career Highlights: James M Kovacs has been associated with the University of Colorado, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of complement system modulation and its potential therapeutic applications.
Collaborations: He has collaborated with notable colleagues, including Jonathan P Hannan and V Michael Holers, to further enhance the impact of his research in the field.
Conclusion: James M Kovacs is a prominent inventor whose work on CR2 targeting groups has the potential to revolutionize the delivery of complement activity modulators. His contributions to the field are significant and continue to influence research and development in complement system modulation.